About: Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody that attenuates the basic function of CCL24 as a regulator of major inflammatory and fibrotic pathways, which has completed phase 2 clinical trial for treating primary sclerosing cholangitis, as well as in phase 2 clinical trial to treat systemic sclerosis. The company was founded in 2011 and is based in Tel Aviv-Yafo, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.12 (+1.82%)
CMMB NASDAQ Chemomab Therapeutics Ltd DRC
Chemomab Therapeutics Ltd DRC share price
Atividade de preço de CMMB
Último preço
$ 1,090
Variação (24h)
-0,01 USD (0,91%)
Volume
41.05K
Volume (média 4 sem.)
-
Abertura
$ 1,10
Variação do dia
$ 1,09 - $ 1,19
Fechamento anterior
$ 1,10
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
CMMB price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals